Revenue
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Thermo Fisher Scientific Inc. (TMO)
Price$675.00Cached quote
Net income
2007
2008
2009
2010
2011
2012
2013
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $44.56B | $42.88B | $42.86B | $44.91B | $39.21B | $32.22B | $25.54B | $24.36B | $20.92B | $18.27B | $16.96B | $16.89B | $13.09B | $12.51B | $11.56B | $10.39B | $9.91B | $10.50B | $9.75B |
| Gross profit | $18.24B | $17.70B | $17.10B | $18.97B | — | — | — | — | $11.94B | $10.06B | $9.38B | $8.95B | $6.78B | $6.41B | $5.83B | $5.13B | $4.76B | $5.20B | $4.67B |
| Gross margin | 40.94% | 41.28% | 39.90% | 42.24% | — | — | — | — | 57.09% | 55.05% | 55.30% | 53.02% | 51.80% | 51.23% | 50.40% | 49.34% | 47.98% | 49.52% | 47.89% |
| Research & development | $1.40B | $1.39B | $1.34B | $1.47B | $1.41B | $1.18B | $1.00B | $967.0M | $887.0M | $754.0M | $692.0M | $691.1M | $395.5M | $376.4M | $340.2M | $284.4M | $243.8M | $249.1M | $238.7M |
| Operating expenses | $36.81B | $35.54B | $36.00B | $36.52B | $29.18B | $24.42B | $20.95B | $20.57B | $17.96B | $15.82B | $14.63B | $14.39B | $11.48B | $11.03B | $10.31B | $9.21B | $8.91B | $9.27B | $8.77B |
| Operating income | $7.75B | $7.34B | $6.86B | $8.39B | $10.03B | $7.79B | $4.59B | $3.78B | $2.96B | $2.46B | $2.34B | $2.50B | $1.61B | $1.48B | $1.25B | $1.19B | $1.00B | $1.23B | $974.4M |
| Operating margin | 17.38% | 17.11% | 16.00% | 18.69% | 25.57% | 24.19% | 17.99% | 15.53% | 14.15% | 13.45% | 13.77% | 14.82% | 12.30% | 11.85% | 10.82% | 11.43% | 10.11% | 11.71% | 10.00% |
| EBITDA | $10.53B | $10.45B | $10.27B | $11.77B | $12.62B | $10.12B | $6.87B | $6.05B | $4.99B | $4.22B | $4.02B | $4.19B | $2.61B | $2.47B | $2.11B | $1.93B | $1.76B | $2.02B | $1.73B |
| EBITDA margin | 23.62% | 24.36% | 23.95% | 26.21% | 32.18% | 31.41% | 26.90% | 24.84% | 23.87% | 23.07% | 23.72% | 24.80% | 19.93% | 19.71% | 18.26% | 18.55% | 17.81% | 19.26% | 17.76% |
| Net income | $6.70B | $6.33B | $6.00B | $6.96B | $7.73B | $6.38B | $3.70B | — | — | — | — | — | $1.27B | $1.18B | $1.33B | $1.04B | $850.3M | $980.9M | $748.4M |
| Net profit margin | 15.05% | 14.77% | 13.99% | 15.50% | 19.71% | 19.79% | 14.48% | — | — | — | — | — | 9.73% | 9.42% | 11.51% | 9.96% | 8.58% | 9.34% | 7.68% |
| Basic EPSper basic share | $17.77 | $16.58 | $15.52 | $17.75 | $19.62 | $16.09 | $9.24 | $7.31 | $5.64 | $5.12 | $4.96 | $4.76 | $3.53 | $3.24 | $3.49 | $2.57 | $2.06 | $2.34 | $1.77 |
| Diluted EPSper diluted share | $17.74 | $16.53 | $15.45 | $17.63 | $19.46 | $15.96 | $9.17 | $7.24 | $5.59 | $5.09 | $4.92 | $4.71 | $3.48 | $3.21 | $3.46 | $2.53 | $2.01 | $2.25 | $1.69 |
Owners
Reported shareholders
≈8.36%of listed shares
BlackRock, Inc.30.92M shares · Jun 30, 2026
View holders
| Holder | % owned |
|---|---|
BlackRock, Inc. | ≈8.36%30.92M shares |
VANGUARD CAPITAL MANAGEMENT LLC | ≈6.57%24.28M shares |
STATE STREET CORP | ≈4.55%16.83M shares |
FMR LLC | ≈3.81%14.08M shares |
MORGAN STANLEY | ≈2.91%10.76M shares |
JPMORGAN CHASE & CO | ≈2.30%8.5M shares |
GEODE CAPITAL MANAGEMENT, LLC | ≈2.27%8.38M shares |
FRANKLIN RESOURCES INC | ≈1.97%7.27M shares |
VANGUARD PORTFOLIO MANAGEMENT LLC | ≈1.68%6.23M shares |
Capital World Investors | ≈1.68%6.2M shares |
PRICE T ROWE ASSOCIATES INC /MD/ | ≈1.38%5.12M shares |
NORGES BANK | ≈1.38%5.09M shares |
Capital Research Global Investors | ≈1.12%4.15M shares |
Bank of New York Mellon Corp | ≈1.07%3.94M shares |
BANK OF AMERICA CORP /DE/ | ≈1.05%3.9M shares |
ROYAL BANK OF CANADA | ≈0.93%3.43M shares |
NORTHERN TRUST CORP | ≈0.90%3.33M shares |
Capital International Investors | ≈0.86%3.18M shares |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | ≈0.84%3.11M shares |
Dodge & Cox | ≈0.83%3.05M shares |
Percentages use 369.75M shares of this listed class outstanding on Jun 27, 2026. ≈ compares the latest reported holding with a share total from a different date; it is not a confirmed current stake.
Gray completes the 100% scale. Reported positions may overlap; holders have different reporting dates.
Source: SEC Form 13F ↗Updated Sep 29, 2026 · Quarterly data
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 27, 2026Form 4 · 10b5-1 | Pettiti GianlucaPresident & COO | SellCommon Stock | 400 | $462.66 | $185.1K | 25.1K |
| Mar 11, 2026Form 4 · 10b5-1 | Shafer Michael DExecutive Vice President | SellCommon Stock | 1.6K | $499.40 | $802.5K | 20.9K |
| Mar 5, 2026Form 4 · 10b5-1 | CASPER MARC NChairman & CEO | SellCommon Stock | 264 | $519.74 | $137.2K | 123.9K |
| Mar 5, 2026Form 4 · 10b5-1 | CASPER MARC NChairman & CEO | SellCommon Stock | 516 | $519.13 | $267.9K | 124.2K |
| Mar 5, 2026Form 4 · 10b5-1 | CASPER MARC NChairman & CEO | SellCommon Stock | 106 | $517.83 | $54.9K | 124.7K |